TrialFind
Saved trials
Back to results
Unknown
Phase 3
Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer
NCT01479036
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Xijing Hospital
Xi'an, Shaanxi, China
Contact
Jianghao Chen, MD, PhD
86-29-84775271
chenjh@fmmu.edu.cn
View on ClinicalTrials.gov
Official details
Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer — TrialFind